S V Gerasimov1, V A Ivantsiv2, L M Bobryk2, O O Tsitsura3, L P Dedyshin1, N V Guta2, B V Yandyo2. 1. Department of Pediatrics, Lviv National Medical University, Lviv, Ukraine. 2. Department of Pediatrics, Lviv City Children Hospital, Lviv, Ukraine. 3. Department of Pediatrics, Ivano-Frankivsk National Medical University, Ivano-Frankivsk, Ukraine.
Abstract
BACKGROUND/ OBJECTIVES: Evidence suggests that the long-term consumption of probiotics may help in reducing the incidence of or modifying acute respiratory infection (ARI). We assessed the role of the short-term use of probiotics in ARI in children. SUBJECTS/ METHODS: This was a randomized, double-blind, controlled study that enrolled 315 children with 90 dropouts. On the first day of appearance of a sick household member, otherwise healthy children of both sexes aged 3-12 years were allocated to receive Lactobacillus acidophilus DDS-1 and Bifidobacterium lactis UABLA-12 (Up4-Junior) in a dose of 5 billion colony-forming units daily with 50 mg of fructooligosaccharide (the probiotic group) or rice maltodexrin (the control group). Test supplementation and follow-up lasted for 2 weeks or until the end of the secondary ARI in a child. The primary outcome measure was the incidence of ARI. Time to resolution and the severity of ARI served the secondary outcome measures. RESULTS: In all, 64 of 113 children in the probiotic group (57%) and 73 of 112 children in the control group (65%) developed ARI (P=0.261). Time to resolution of the secondary ARI was shorter in the probiotic group (5.0 (interquartile range (IQR): 4.0-6.0) vs 7.0 (IQR: 6.0-8.0) days, P<0.001). The median severity of ARI was 240 (IQR: 163-350) score-days in the probiotic vs 525 (IQR: 364-736) score-days in the control group (P<0.001). CONCLUSIONS: The short-term use of probiotics does not reduce the incidence, but shortens ARI in preschool and elementary school children.
RCT Entities:
BACKGROUND/ OBJECTIVES: Evidence suggests that the long-term consumption of probiotics may help in reducing the incidence of or modifying acute respiratory infection (ARI). We assessed the role of the short-term use of probiotics in ARI in children. SUBJECTS/ METHODS: This was a randomized, double-blind, controlled study that enrolled 315 children with 90 dropouts. On the first day of appearance of a sick household member, otherwise healthy children of both sexes aged 3-12 years were allocated to receive Lactobacillus acidophilusDDS-1 and Bifidobacterium lactisUABLA-12 (Up4-Junior) in a dose of 5 billion colony-forming units daily with 50 mg of fructooligosaccharide (the probiotic group) or ricemaltodexrin (the control group). Test supplementation and follow-up lasted for 2 weeks or until the end of the secondary ARI in a child. The primary outcome measure was the incidence of ARI. Time to resolution and the severity of ARI served the secondary outcome measures. RESULTS: In all, 64 of 113 children in the probiotic group (57%) and 73 of 112 children in the control group (65%) developed ARI (P=0.261). Time to resolution of the secondary ARI was shorter in the probiotic group (5.0 (interquartile range (IQR): 4.0-6.0) vs 7.0 (IQR: 6.0-8.0) days, P<0.001). The median severity of ARI was 240 (IQR: 163-350) score-days in the probiotic vs 525 (IQR: 364-736) score-days in the control group (P<0.001). CONCLUSIONS: The short-term use of probiotics does not reduce the incidence, but shortens ARI in preschool and elementary school children.
Authors: Brylee A Haywood; Katherine E Black; Dane Baker; James McGarvey; Phil Healey; Rachel C Brown Journal: J Sci Med Sport Date: 2013-08-30 Impact factor: 4.319
Authors: E Kathryn Miller; John V Williams; Tebeb Gebretsadik; Kecia N Carroll; William D Dupont; Yassir A Mohamed; Laura-Lee Morin; Luke Heil; Patricia A Minton; Kimberly Woodward; Zhouwen Liu; Tina V Hartert Journal: J Allergy Clin Immunol Date: 2011-01-26 Impact factor: 10.793
Authors: I Garaiova; J Muchová; Z Nagyová; D Wang; J V Li; Z Országhová; D R Michael; S F Plummer; Z Ďuračková Journal: Eur J Clin Nutr Date: 2014-09-10 Impact factor: 4.016
Authors: Anna M Scott; Justin Clark; Blair Julien; Farhana Islam; Kristian Roos; Keith Grimwood; Paul Little; Chris B Del Mar Journal: Cochrane Database Syst Rev Date: 2019-06-18
Authors: Sarah King; Daniel Tancredi; Irene Lenoir-Wijnkoop; Kelsie Gould; Hailey Vann; Grant Connors; Mary Ellen Sanders; Jeffrey A Linder; Andi L Shane; Dan Merenstein Journal: Eur J Public Health Date: 2019-06-01 Impact factor: 3.367
Authors: Ravichandra Vemuri; Rohit Gundamaraju; Tanvi Shinde; Agampodi Promoda Perera; Waheedha Basheer; Benjamin Southam; Shakuntla V Gondalia; Avinash V Karpe; David J Beale; Stephen Tristram; Kiran D K Ahuja; Madeleine Ball; Christopher J Martoni; Rajaraman Eri Journal: Nutrients Date: 2019-06-07 Impact factor: 5.717
Authors: Ravichandra Vemuri; Tanvi Shinde; Madhur D Shastri; Agampodi Promoda Perera; Stephen Tristram; Christopher J Martoni; Rohit Gundamaraju; Kiran D K Ahuja; Madeleine Ball; Rajaraman Eri Journal: Int J Med Sci Date: 2018-05-26 Impact factor: 3.738